Freshness note: This analysis was last updated 26 days ago. Fast-moving policy claims can change quickly, so check for newer official updates before relying on this verdict.
“President Donald Trump said Americans are now paying or will pay 'the lowest price anywhere in the world for drugs' due to administration negotiations with pharmaceutical companies”
Summary
President Trump claimed Americans are paying or will pay the lowest drug prices in the world due to his administration's negotiations with pharmaceutical companies. According to fact-checkers, this claim is not supported by available evidence, as Americans continue to pay significantly higher prices for prescription drugs compared to other developed nations, and the announced agreements do not establish the lowest prices globally.
Primary Sources
FactCheck.org rated Trump's claim about Americans paying the lowest drug prices in the world as misleading, finding the assertion not supported by evidence
Evidence Supporting the Claim
- The Trump administration announced negotiations with pharmaceutical companies regarding drug pricing
Evidence Against / Context
- FactCheck.org rated the claim as misleading, indicating Americans are not paying the lowest drug prices in the world
- Historical data shows Americans have consistently paid higher prescription drug prices compared to other developed countries
- The specific agreements announced do not establish the United States as having the lowest drug prices globally
Timeline
President Trump made public statements claiming Americans are paying or will pay the lowest drug prices in the world due to administration negotiations
FactCheck.org published analysis rating the claim as misleading
What This Means
Structured interpretation — not opinion
Key takeaway 1
The claim extends beyond what available evidence supports regarding comparative international drug pricing
Key takeaway 2
While pharmaceutical company negotiations may have occurred, they have not resulted in the United States having the lowest drug prices globally
Key takeaway 3
International comparisons continue to show Americans paying higher prices for prescription drugs than consumers in other developed nations
Related Claims in Healthcare
“Florida used an emergency rule to cut patients off AIDS medication”
Florida's Agency for Health Care Administration implemented an emergency rule in February 2025 that restricted eligibility for the AIDS Drug Assistance Program (ADAP), resulting in approximately 1,100 patients losing access to HIV/AIDS medications. The rule changed income eligibility thresholds and was challenged by the AIDS Healthcare Foundation in administrative proceedings.
“The Trump administration is withholding $259 million in Minnesota Medicaid funds, citing fraud”
On February 26, 2025, Vice President JD Vance announced that the Trump administration would withhold $259 million in federal Medicaid reimbursements from Minnesota, citing alleged fraud in the state's Medicaid program. Minnesota officials confirmed the withholding and disputed the fraud allegations, indicating they would pursue legal action.
“Dr. Mehmet Oz is advancing a $50 billion plan to modernize rural health care using AI avatars”
Dr. Mehmet Oz, as Administrator of the Centers for Medicare and Medicaid Services, has discussed AI-powered virtual health assistants as part of rural healthcare modernization efforts. While CMS has announced significant investments in telehealth and AI initiatives for underserved areas, the specific characterization of a '$50 billion plan' for 'AI avatars' oversimplifies a broader set of healthcare modernization proposals that include multiple technologies and funding streams.